White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators
White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators
J&J is working closely with regulators to resolve the issues holding up authorization, said Jeff Zients, the White House's COVID-19 response coordinator. It expects to start shipping 8 million doses per week towards the end of April and remains on track to deliver around 100 million shots by the end of May, he added.
(Reporting by Carl O'Donnell)
((Carl.ODonnell@thomsonreuters.com; 646-223-6629;)
April 9 (Reuters) - Johnson & Johnson will ship relatively few COVID-19 shots around the United States until it receives regulatory clearance for a large vaccine plant in Baltimore that has struggled to meet quality control standards, a top White House Health official said on a Friday press conference.
J&J is working closely with regulators to resolve the issues holding up authorization, said Jeff Zients, the White House's COVID-19 response coordinator. It expects to start shipping 8 million doses per week towards the end of April and remains on track to deliver around 100 million shots by the end of May, he added.
(Reporting by Carl O'Donnell)
((Carl.ODonnell@thomsonreuters.com; 646-223-6629;)
路透4月9日電-白宮一位高級衞生官員在週五的新聞發佈會上表示，在巴爾的摩一家大型疫苗廠獲得監管批准之前，強生公司將在美國各地運送相對較少的新冠肺炎疫苗。該廠一直難以達到質量控制標準。白宮新冠肺炎迴應協調員齊恩茨(Jeff Zients)説，強生正在與監管機構密切合作，以解決阻礙授權的問題。他補充説，該公司預計將在4月底開始每週運送800萬劑疫苗，並保持在5月底之前交付約1億劑疫苗的軌道上。(Carl O‘Donnell報道)(Carl.ODonnell@thomsonreurs.com；646-223-6629；)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧